Catalyst event

Recursion Pharmaceauticals Inc (RXRX)

From KEDI U.S. Medical AI Index (KUSMAI)

Recursion is estimated to report second-quarter 2026 results on August 4, 2026, with third-party consensus EPS now approximately -$0.25.

Korean translation

Recursion은 2026년 8월 4일 2분기 실적을 발표할 것으로 추정되며, 외부 컨센서스 EPS는 현재 약 -0.25달러임.